Impaired Platelet Function and Thrombus Formation in PDE5A-Deficient Mice

Area of Science:

• Biochemistry
• Hematology
• Pharmacology

Background:

• Intracellular cyclic GMP (cGMP) regulates platelet function.
• Phosphodiesterase 5A (PDE5A) controls platelet cGMP levels through degradation.
• The precise role of PDE5A in platelet activity and thrombus development requires further elucidation.

Purpose of the Study:

• To investigate the function of PDE5A in platelet activation and thrombus formation.
• To characterize the effects of PDE5A deficiency on various platelet functions and in vivo thrombosis models.

Main Methods:

• Utilized wild-type and PDE5A-deficient mouse models.
• Assessed platelet aggregation, activation, phosphatidylserine exposure, ROS generation, spreading, and clot retraction.
• Evaluated in vivo arterial and venous thrombosis, tail bleeding time, and in vitro thrombus formation via microfluidic assays.
• Measured protein phosphorylation (VASP, ERK1/2, p38, JNK, AKT) and calcium mobilization.

Main Results:

• PDE5A deficiency led to prolonged bleeding times and delayed thrombus formation in vivo.
• Platelet aggregation, ATP release, P-selectin expression, and integrin activation were significantly inhibited in PDE5A-deficient platelets.
• Impaired platelet spreading, clot retraction, reduced phosphatidylserine exposure, calcium mobilization, and ROS production were observed.
• PDE5A deficiency increased intracellular cGMP levels, elevated VASP phosphorylation, and decreased phosphorylation of ERK1/2, p38, JNK, and AKT.

Conclusions:

• PDE5A plays a significant role in modulating platelet activation, function, and thrombus formation.
• Targeting PDE5A therapeutically could be a promising strategy for managing thrombotic disorders.